1. Home
  2. SCLX vs AHMA Comparison

SCLX vs AHMA Comparison

Compare SCLX & AHMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SCLX
  • AHMA
  • Stock Information
  • Founded
  • SCLX 2011
  • AHMA 2007
  • Country
  • SCLX United States
  • AHMA United Arab Emirates
  • Employees
  • SCLX N/A
  • AHMA N/A
  • Industry
  • SCLX Biotechnology: Pharmaceutical Preparations
  • AHMA Services-Misc. Amusement & Recreation
  • Sector
  • SCLX Health Care
  • AHMA Consumer Discretionary
  • Exchange
  • SCLX Nasdaq
  • AHMA Nasdaq
  • Market Cap
  • SCLX 139.3M
  • AHMA 150.7M
  • IPO Year
  • SCLX N/A
  • AHMA 2025
  • Fundamental
  • Price
  • SCLX $15.30
  • AHMA $4.68
  • Analyst Decision
  • SCLX Hold
  • AHMA
  • Analyst Count
  • SCLX 1
  • AHMA 0
  • Target Price
  • SCLX N/A
  • AHMA N/A
  • AVG Volume (30 Days)
  • SCLX 140.1K
  • AHMA 460.3K
  • Earning Date
  • SCLX 08-13-2025
  • AHMA 12-01-2025
  • Dividend Yield
  • SCLX N/A
  • AHMA N/A
  • EPS Growth
  • SCLX N/A
  • AHMA N/A
  • EPS
  • SCLX N/A
  • AHMA 0.03
  • Revenue
  • SCLX $40,360,000.00
  • AHMA $18,543,447.00
  • Revenue This Year
  • SCLX $89.26
  • AHMA N/A
  • Revenue Next Year
  • SCLX $203.95
  • AHMA N/A
  • P/E Ratio
  • SCLX N/A
  • AHMA $136.93
  • Revenue Growth
  • SCLX N/A
  • AHMA N/A
  • 52 Week Low
  • SCLX $3.60
  • AHMA $4.00
  • 52 Week High
  • SCLX $34.27
  • AHMA $7.48
  • Technical
  • Relative Strength Index (RSI)
  • SCLX 42.42
  • AHMA N/A
  • Support Level
  • SCLX $17.28
  • AHMA N/A
  • Resistance Level
  • SCLX $19.56
  • AHMA N/A
  • Average True Range (ATR)
  • SCLX 1.97
  • AHMA 0.00
  • MACD
  • SCLX -0.02
  • AHMA 0.00
  • Stochastic Oscillator
  • SCLX 3.68
  • AHMA 0.00

About SCLX Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.

About AHMA Ambitions Enterprise Management Co. L.L.C Class A Ordinary Shares

Ambitions Enterprise Management Co LLC, through its subsidiaries in the UAE, operates as a tour operator, travel agency, and event planning and management services provider. It provides two lines of services, namely, MICE management, a comprehensive coordination and organization of events, and one-stop tourism, a comprehensive travel product that is designed to provide tourists with all the necessary components of a trip in a single and convenient package, which typically include transportation, accommodations, meals, and guided tours or activities.

Share on Social Networks: